Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death.
- DOI
- 10.21037/tcr-24-698
- Published
- 2024 Jun 30
- Container
- Translational cancer research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/tcr-24-698,
title = {Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death.},
author = {Zhu X and Zhang W and Yu Z and Yang X and Li L and Chen C and Djumanazarov T and Piquemal D and Yusupbekov AA and Zheng Y},
year = {2024},
journal = {Translational cancer research},
doi = {10.21037/tcr-24-698},
url = {https://doi.org/10.21037/tcr-24-698}
}RIS
TY - JOUR TI - Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death. AU - Zhu X AU - Zhang W AU - Yu Z AU - Yang X AU - Li L AU - Chen C AU - Djumanazarov T AU - Piquemal D AU - Yusupbekov AA AU - Zheng Y PY - 2024 JO - Translational cancer research DO - 10.21037/tcr-24-698 UR - https://doi.org/10.21037/tcr-24-698 ER -
APA
X, Z., W, Z., Z, Y., X, Y., L, L., C, C., T, D., D, P., AA, Y., & Y, Z. (2024). Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death.. Translational cancer research. https://doi.org/10.21037/tcr-24-698
Source records
- pubmed · retrieved 2026-09-26T00:48:48.384Z